StockWise AI Analysis Lab

AI Stock Analysis, Built From Real NSE Data.

See what happens when an AI receives structured historical market data instead of just a stock symbol.

Explore the Analysis See the Dataset
5 NSE Stocks Swing Horizon: 5–30 Days 63 Trading Sessions AI of Your Choice
The workflow

Market data becomes an AI-ready research input.

StockWise prepares structured historical NSE data. You decide which AI you want to use to interpret it.

01

Market Data

Historical NSE price, volume, delivery and indicator data.

02

StockWise

Organises the data into a structured, AI-ready dataset.

03

Prompt

A defined analysis framework tells the AI how to interpret the data.

04

Your AI

Use ChatGPT, Claude, Gemini or another AI of your choice.

Live demonstration

Five stocks. One dataset. No forced trades.

This example uses a 5–30 trading-day swing framework. Each stock is analysed independently. Where the evidence is weak or the risk/reward is unattractive, the analysis can say “Watch” or “No Trade”.

5Stocks analysed
63Trading sessions
5–30dAnalysis horizon
90dCalendar lookback
AARTIDRUGS
Aarti Drugs Ltd.
BullishWatch

Above the major moving averages and VWAP, with resistance being tested. The technical picture is constructive, but the immediate risk/reward is not especially attractive at the current price.

₹437.25Current
₹443.26Resistance
₹426.50Support
BiasLong, conditional
SetupBreakout / continuation
TriggerAbove ₹443.25–444 with volume confirmation
VolumeLatest 3.9L vs 20D average 1.6L
Target 1Approx. ₹460
Target 2Approx. ₹475
Stop contextAround ₹426, subject to confirmation
ConfidenceMedium
Important: bullish outlook does not automatically mean a trade. The setup should be confirmed and the risk/reward should remain acceptable.
AUROPHARMA
Aurobindo Pharma Ltd.
BullishWatch

Price is above the major moving averages and has reached a fresh 52-week high. The trend is strong, but the lack of substantial volume expansion argues against blindly chasing the move.

₹1,716Current
₹1,74052W High
₹1,685Support
BiasLong, conditional
SetupBreakout
TriggerSustained move above ₹1,740 with volume
VolumeLatest 8.2L vs 20D average 8.2L
Pullback area₹1,685–1,700
Expected rangeApprox. ₹1,650–1,820
RiskBreakout failure / loss of support
ConfidenceMedium
A strong trend and a good entry are not necessarily the same thing. The analysis deliberately avoids treating a new high as an automatic buy signal.
RAYMOND
Raymond Ltd.
BullishNo Trade

The price has made an explosive move and is far above its major moving averages. The latest delivery percentage is low, while the supplied dataset does not provide usable structural support levels for a fresh entry.

₹1,203.85Current
₹1,22152W High
₹92.45ATR-14
BiasNo fresh long entry
SetupMomentum continuation, but extended
Recent moveApprox. ₹600 to ₹1,204 since early August
VolumeLatest 74.7L vs 20D average 64.2L
Delivery11.64%
RiskSharp mean reversion after extension
Structural levelsNot supplied; none invented
ConfidenceMedium / Low
This is a useful example of analytical restraint: a stock can have a strong recent trend while still producing “No Trade” at the current entry point.
SUBEXLTD
Subex Ltd.
BullishWatch

The broader trend is positive, but the stock is volatile. The recent peak was followed by a sharp retreat, making confirmation more important than simply buying into the move.

₹20.71Current
₹22.80Recent High
₹1.62ATR-14
BiasLong, conditional
SetupContinuation / range breakout
TriggerReclaim ₹22.20–22.80 and hold
VolumeLatest 2.0Cr vs 20D average 1.5Cr
DeliveryNot applicable for BE series
Potential targetApprox. ₹24.50 then ₹26
RiskFailure near recent high / high volatility
ConfidenceMedium / Low
The BE series does not provide delivery data in this dataset, so the analysis does not invent or substitute a delivery figure.
ZYDUSWELL
Zydus Wellness Ltd.
WeakeningNo Trade

Price is below the 20, 30 and 50-day moving averages and below VWAP. A key support has been breached, but the latest volume is far below the 20-day average, so there is insufficient confirmation for a fresh directional trade.

₹520.15Current
₹512.51Strong Support
₹539.19DMA20
BiasNo trade currently
SetupNone
Bullish triggerReclaim ₹526–527, then ₹539–545
Bearish triggerBreak below ₹512.50 with volume
Latest volume66.2K
20D volume6.0L
VWAP₹544.85
ConfidenceMedium
The very low latest volume means the recent weakness is not treated as a fully confirmed breakdown.
Inside the analysis

What did the AI actually receive?

The important part is not only the final answer. You can inspect the dataset and the instructions supplied to the AI.

SymbolDateOpenHighLowCloseVolumeDelivery %DMA20DMA50
AARTIDRUGS2026-09-24436.35450.20434.60437.2539000039.13426.48420.66
AUROPHARMA2026-09-241719.701740.001710.001716.0082000045.251679.911629.77
RAYMOND2026-09-241114.651221.001100.001203.85747000011.64871.79718.15
SUBEXLTD2026-09-2421.9022.2220.3120.7120000000N/A19.1116.11
ZYDUSWELL2026-09-24529.00529.45518.60520.156620040.80539.19539.86
The table above is a compact demonstration view. In production, this tab can load the complete CSV generated by StockWise, including all historical sessions and indicators.
STOCKWISE AI — ANALYSIS RULES

Trade Type: SWING
Horizon: 5–30 trading days
Lookback: 90 calendar days (~60 sessions)

Analyze each stock independently. Do not compare stocks unless explicitly requested.

Prioritize:
1. Recent Price Action
2. Volume + Delivery
3. Trend
4. Momentum
5. Volatility

Do not blindly follow any supplied Score or Score Rating.

If evidence is insufficient, state:
"No Clear Trade Setup."

For each stock provide:
- Overall Outlook
- Trade Bias
- Swing Setup
- Setup Type
- Current Phase
- Trigger Condition
- Support / Resistance
- Entry
- Target 1
- Target 2 where appropriate
- Stop Loss
- Risk/Reward
- Breakout probability
- Breakdown probability
- Range-bound probability
- Expected Swing Range
- Volume & Delivery interpretation
- Risk / Invalidation
- Setup Confidence
- Trade Decision

Probabilities are dataset-based scenario estimates and are not statistically calibrated forecasts.

Never invent missing market data, support levels or delivery information.
AARTIDRUGS
Outlook: Bullish
Bias: Long, conditional
Decision: Watch
Reason: Trend is constructive, but immediate risk/reward is not especially attractive.

AUROPHARMA
Outlook: Bullish
Bias: Long, conditional
Decision: Watch
Reason: Strong trend and fresh 52-week high, but confirmation is required rather than chasing.

RAYMOND
Outlook: Bullish, highly extended
Bias: No fresh long entry
Decision: No Trade
Reason: Explosive move, low delivery and insufficient supplied structural support levels.

SUBEXLTD
Outlook: Bullish but volatile
Bias: Long, conditional
Decision: Watch
Reason: Trend remains positive but recent volatility makes confirmation important.

ZYDUSWELL
Outlook: Weakening
Bias: No trade currently
Decision: No Trade
Reason: Below major moving averages and VWAP, with insufficient volume confirmation.
A useful distinction

The AI does not simply follow a score.

StockWise can provide scores and indicators, but the analysis framework tells the AI to interpret the complete dataset rather than blindly converting one number into a trade.

RAYMOND is the example.

Its supplied score was only 10, while the price had risen dramatically and was trading far above its major moving averages. The analysis therefore considered price structure, extension, volume, delivery and available support information separately.

Score: 10
Current price: ₹1,203.85
DMA20: ₹871.79

Analytical restraint matters.

A useful AI workflow should be capable of saying that a stock is trending strongly but that the current entry is unattractive.

That is why the example contains bullish stocks, watch situations and no-trade situations rather than five forced recommendations.

Run it on your own data

Generate your own AI-ready NSE dataset.

StockWise prepares structured historical market data that you can take to ChatGPT, Claude, Gemini or another AI of your choice.

Download on Android Inspect This Example